Martine A. Rothblatt - 15 Mar 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Chairperson & CEO, Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:09:17 UTC
Previous filing
16 Mar 2026
Next filing
17 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROTHBLATT MARTINE A Chairperson & CEO, Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 17 Mar 2026 0001106578

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise +32,499 +24999% 32,629 15 Mar 2026 Direct F1
transaction UTHR Common Stock Options Exercise +37,080 +114% 69,709 15 Mar 2026 Direct F1
transaction UTHR Common Stock Tax liability -13,637 -20% $536.12* 56,072 15 Mar 2026 Direct F2
transaction UTHR Common Stock Tax liability -15,559 -28% $536.12* 40,513 15 Mar 2026 Direct F2
holding UTHR Common Stock 166 15 Mar 2026 by Spouse
holding UTHR Common Stock 324,518 15 Mar 2026 by Trust F3
holding UTHR Common Stock 258,117 15 Mar 2026 by Trust F4
holding UTHR Common Stock 45,596 15 Mar 2026 by Trust F5
holding UTHR Common Stock 10,962 15 Mar 2026 by Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Units Options Exercise -32,499 -100% $0.000000* 0 15 Mar 2026 Common Stock 32,499 Direct F1, F7
transaction UTHR Restricted Stock Units Options Exercise -37,080 -100% $0.000000* 0 15 Mar 2026 Common Stock 37,080 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2 Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
F3 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
F4 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
F5 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
F6 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
F7 Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2026.